{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:40:47Z","timestamp":1685076047926},"reference-count":3,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tierarztl Prax Ausg G Grosstiere Nutztiere"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Im Jahr 2022 kam f\u00fcr Pferde und landwirtschaftliche Nutztiere ein neuer\n                    Wirkstoff auf den deutschen Tierarzneimittelmarkt. So steht erstmalig\n                    f\u00fcr Pferde eine Injektionssuspension mit tenogen geprimten allogenen,\n                    aus peripherem Blut gewonnenen mesenchymalen Stammzellen von Pferden zur\n                    Verf\u00fcgung (RenuTend\u00ae). Ein Wirkstoff erhielt eine\n                    Tierartenerweiterung. So wurde das synthetische Prostaglandin\n                        F2\u03b1-Analogon Cloprostenol\n                        (Syncroprost\u00ae) auch f\u00fcr Ziegen zugelassen.\n                    Au\u00dferdem kamen f\u00fcr 2 Wirkstoffe (Paracetamol, Suxibuzon)\n                    Arzneimittel mit einem h\u00f6heren Wirkstoffgehalt f\u00fcr Pferde und\n                    landwirtschaftliche Nutztiere auf den Markt.<\/jats:p>","DOI":"10.1055\/a-2062-7397","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T22:53:53Z","timestamp":1685055233000},"page":"93-96","source":"Crossref","is-referenced-by-count":0,"title":["Neue Arzneimittel f\u00fcr Gro\u00dftiere 2022"],"prefix":"10.1055","volume":"51","author":[{"given":"Ilka Ute","family":"Emmerich","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pharmakologie, Pharmazie und Toxikologie,\n                    Veterin\u00e4rmedizinische Fakult\u00e4t der Universit\u00e4t\n                    Leipzig"}]}],"member":"194","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref3","doi-asserted-by":"publisher","first-page":"102963","DOI":"10.1016\/j.scr.2022.102963","article-title":"Assessing the functional properties of tenogenic primed mesenchymal stem cells\n                    in ex vivo equine tendon and ligament explants: A preliminary study","volume":"65","author":"E Depuydt","year":"2022","journal-title":"Stem Cell Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"789293","DOI":"10.3389\/fvets.2021.789293","article-title":"Cellular and Humoral Immunogenicity Investigation of Single and Repeated\n                    Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering\n                    From Tendon Injuries","volume":"8","author":"E Depuydt","year":"2022","journal-title":"Front Vet Sci"},{"key":"ref8","first-page":"399","volume-title":"ed. Cloprostenol. In: Plumb\u2019s Veterinary Drug Handbook, 9th ed","author":"D C Plumb","year":"2018"}],"container-title":["Tier\u00e4rztliche Praxis Ausgabe G: Gro\u00dftiere \/ Nutztiere"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2062-7397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T22:54:39Z","timestamp":1685055279000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2062-7397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":3,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"http:\/\/dx.doi.org\/10.1055\/a-2062-7397","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1434-1220","2567-5834"],"issn-type":[{"value":"1434-1220","type":"print"},{"value":"2567-5834","type":"electronic"}],"subject":["General Veterinary","Food Animals"],"published":{"date-parts":[[2023,4]]}}}